Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 381,733
  • Shares Outstanding, K 1,363,334
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.73
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings 0.00 on 09/30/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.190 +23.68%
on 03/13/19
0.330 -28.79%
on 02/26/19
-0.040 (-14.55%)
since 02/20/19
3-Month
0.190 +23.68%
on 03/13/19
0.445 -47.19%
on 01/10/19
-0.060 (-20.34%)
since 12/20/18

Most Recent Stories

More News
Cannabis and Cleantech; The Green, Clean Machine of The Future

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing interest in renewable energy and sustainable practices within the cannabis...

ACB : 9.64 (-3.21%)
ACBFF : 8.6900 (-12.80%)
LIHT.CN : 0.240 (+4.35%)
FSDDF : 0.1670 (-1.76%)
SING : 0.0180 (unch)
HUGE.CN : 0.240 (+4.35%)
LIHTF : 0.1754 (-1.74%)
FSD Pharma Looks to Grow Cannabinoids in Algae -- CFN Media

via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article looking at what...

FSDDF : 0.1670 (-1.76%)
HUGE.CN : 0.240 (+4.35%)
FSD Pharma Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae

PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S)

SVS.VN : 0.230 (unch)
FSDDF : 0.1670 (-1.76%)
HUGE.CN : 0.240 (+4.35%)
Therapix Biosciences Provides Update Regarding FSD Acquisition

Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, is providing an update...

TRPX : 4.36 (-0.23%)
FSDDF : 0.1670 (-1.76%)
HUGE.CN : 0.240 (+4.35%)
FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

FSD Pharma Inc. ("FSD Pharma" or "FSD") (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of Rupert Haynes as Chief Executive Officer. Mr. Haynes is a highly accomplished...

FSDDF : 0.1670 (-1.76%)
GWPH : 168.88 (+0.46%)
HUGE.CN : 0.240 (+4.35%)
FSD Pharma adds David Urban to Board of Directors

FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of David Urban to the Company's Board of Directors.

FSDDF : 0.1670 (-1.76%)
HUGE.CN : 0.240 (+4.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.253
1st Resistance Point 0.242
Last Price 0.240
1st Support Level 0.217
2nd Support Level 0.203

See More

52-Week High 0.940
Fibonacci 61.8% 0.610
Fibonacci 50% 0.507
Fibonacci 38.2% 0.405
Last Price 0.240
52-Week Low 0.075

See More

Business Summary

FSD Pharma Inc is a publicly traded company. FSD through its wholly-owned subsidiary holds an Access to Cannabis for Medical Purposes Regulation license to cultivate cannabis.

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar